Demo Data from EDBT 2026 / reviewers in the wild / expert
Xinhao Li 0001
dblp:271/4947-1
· DBLP profile ↗
1ranked-venue papers
0as first author
1since 2021 · last 2021
0000-0002-1821-2680ORCID · conflict
Domains — the database's venue-derived domains; a paper can count in several
Artificial intelligence and machine learning · 1 · 1 since 2021Graphics, computer vision, multimedia, augmented reality and games · 1 · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 2 heaviest of 2, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology
drug discovery |
0.5 | 1 | 2021 | MIMOSA: Multi-constraint Molecule Sampling for Molecule Optimization · AAAI 2021 |
Bioinformatics and computational biology › drug discovery
molecular optimization |
0.5 | 1 | 2021 | MIMOSA: Multi-constraint Molecule Sampling for Molecule Optimization · AAAI 2021 |
Methods — techniques the papers use, named apart from their topics
substructure sampling · 0.5reinforcement learning · 0.5graph neural network · 0.5
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2021 | MIMOSA: Multi-constraint Molecule Sampling for Molecule OptimizationabstractMolecule optimization is a fundamental task for accelerating drug discovery, with the goal of generating new valid molecules that maximize multiple drug properties while maintaining similarity to the input molecule. Existing generative models and reinforcement learning approaches made initial success, but still face difficulties in simultaneously optimizing multiple drug properties. To address such challenges, we propose the MultI-constraint MOlecule SAmpling (MIMOSA) approach, a sampling framework to use input molecule as an initial guess and sample molecules from the target distribution. MIMOSA first pretrains two property agnostic graph neural networks (GNNs) for molecule topology and substructure-type prediction, where a substructure can be either atom or single ring. For each iteration, MIMOSA uses the GNNs’ prediction and employs three basic substructure operations (add, replace, delete) to generate new molecules and associated weights. The weights can encode multiple constraints including similarity and drug property constraints, upon which we select promising molecules for next iteration. MIMOSA enables flexible encoding of multiple property- and similarity-constraints and can efficiently generate new molecules that satisfy various property constraints and achieved up to 49.1% relative improvement over the best baseline in terms of success rate. Tianfan Fu, Cao Xiao, Xinhao Li 0001, Lucas Glass, Jimeng Sun 0001 |
AAAI | 3 |